Statistics

Total Visits

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)86

Select a period of time:

Number of views in the range

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)22

Views

Views
November 20258
December 20254
January 20261
February 20260
March 20263
April 20262
May 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom7
United States5
Brazil2
Ecuador2
Mexico2
Argentina2
Algeria1
Paraguay1
 

Top cities views

Views
Quito2
Buffalo1
Contagem1
Culiacán1
Danbury1
Des Moines1
Ghardaïa1
Irapuato1
Lansdowne1
London1